07:27 EDT Phathom Pharmaceuticals (PHAT) sees 2025 revenue $165M-$175M, consensus $159.4M
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PHAT:
- Avidity, Phathom mentioned as potential takeout targets at Needham
- Phathom Pharmaceuticals appoints Anne Marie Cook as CLO, corporate secretary
- Largest borrow rate increases among liquid names
- Phathom Pharmaceuticals Gains FDA Exclusivity for VOQUEZNA
- Phathom Pharmaceuticals announces FDA correction to Orange Book Listing